Dermagnostix is featured in the journal series 'Karger Kompass' aimed at clinicians and specialists in private practice with a focus on young, committed physicians with four specialist target groups of pneumologists, dermatologists, oncologists and ophthalmologists.
More...
With PsorX-LabDisk, the first molecular test worldwide for the differential diagnosis of psoriasis and eczema, which is processed fully automatically in the LabDisk-Analyzer, Dermagnostix shows innovative ways in medicine, which is one of the main topics in the Digital Health section of the Dermatology Compass, along with digital solutions and support for start-up companies in medicine.